How Remdesivir, New Hope for Covid-19 Patients, Was Resurrected - msnNOW
Remdesivir, an antiviral drug designed to treat both hepatitis and a common respiratory virus, seemed fated to join thousands of other failed medications after proving useless against those diseases. The drug was consigned to the pharmaceutical scrap heap, all but forgotten by the scientists who once championed it.
But on Friday, the Food and Drug Administration issued an emergency approval for remdesivir as a treatment for patients severely ill with Covid-19, the disease caused by the coronavirus.
The story of remdesivir’s rescue and transformation testifies to the powerful role played by federal funding, which allowed scientists laboring in obscurity to pursue basic research without obvious financial benefits. This research depends almost entirely on government grants.
Dr. Mark Denison of Vanderbilt University is one of a handful of researchers who discovered remdesivir’s potential. He began studying coronaviruses a quarter-century ago, a time when few scientists cared about them — the ones infecting humans caused colds, he recalled, and scientists just wanted to know how they worked.
“We were interested from the biologic perspective,” Dr. Denison recalled. “No one was interested from a therapeutic perspective.”
Neither he nor the scores of other scientists interested in coronaviruses foresaw that a new one would unleash a plague that has killed nearly a quarter-million people worldwide. The F.D.A. rushed to approve remdesivir under emergency use provisions, after a federal trial demonstrated modest improvements in severely ill patients.
The trial, sponsored by the National Institute of Allergy and Infectious Diseases, included more than 1,000 hospitalized patients and found that those receiving remdesivir recovered faster than those who got a placebo: in 11 days, versus 15 days. But the drug did not significantly reduce fatality rates.
Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, said the results were “a very important proof of concept” but not a “knockout.” President Trump hailed the drug on Friday as “an important treatment and “really promising.”
A pedestrian passes a boarded up business while wearing personal protective equipment to protect against coronavirus, on May 1 in New York.
New York State Governor Andrew Cuomo speaks during his daily press briefing on May 1 in Albany, New York. Cuomo stated that New York will eliminate deductibles for mental health services for frontline workers.
Anti-quarantine and pro-Trump protesters took over the steps of the Pennsylvania State Capitol in Harrisburg, Pennsylvania on May 1.
Manager Roxanne Martinez, talks with waitstaff before opening at El Tiempo Cantina on May 1 in Houston. The restaurant reopened their dining room for table service, with limited capacity, Friday.
Medical professionals and their supporters wearing protective face masks as a precaution against the coronavirus demand safer working conditions and policies during a May Day protest near Temple University Hospital in Philadelphia on May 1.
May Day protesters gather outside the offices of New York Gov. Andrew Cuomo on May 1 in New York.
A sign asked people to maintain social distance as they enjoy the warm weather on May 1 in Atlanta, Georgia.
People wait outside Penn Square Mall for the doors to open on May 1 in Oklahoma City.
The Westin South Coast Plaza hotel is seen lit up with a heart in a message of hope during the coronavirus outbreak on April 30 in Costa Mesa, California.
Aerial view of over 100 vehicles lined up at the West Valley COVID-19 testing center at Warner Center, on April 30, in Woodland Hills, California. Testing for the coronavirus has opened up for public.
A commuter wears a mask while riding the New York City Subway maintaining social distance in Manhattan, on April 30.
Health care workers look on as four members of Hill Air Force Base's 388th Fighter Wing fly in formation over the University of Utah Hospital, on April 30, in Salt Lake City. The flyover was a "thank you" to health care workers, first responders, military members, and essential personnel, as well as those who are staying home to help "flatten the curve".
Postal workers May Chen, left and Wilson Yu wear masks and gloves as they sort mail at the United States Postal Service processing and distribution center, on April 30, in Oakland.
A visitor looks over the tablets to honor past members of the NFL Denver Broncos outside Empower Field at Mile High, on April 30, in Denver.
U.S. President Donald Trump signs a presidential proclamation declaring an "Older Americans Month 2020" during an event about senior citizens and the coronavirus disease (COVID-19) pandemic in the East Room at the White House in Washington, on April 30.
Protesters hold a banner reading 'Food Not Rent' during a rent strike demonstration in front of the Downtown City Hall in Los Angeles, California, on 30 April.
A protester holds a sign at the State Capitol in Lansing, Michigan on April 30.
Vice President Mike Pence gestures while visiting the General Motors/Ventec ventilator production facility in Kokomo, Indiana on April 30.
Beatrice Diaz wears a protective face mask as she passes out pet food at a drive-thru pet food bank held by the Miami-Dade County Animal Services Department during the new coronavirus pandemic on April 30 in Doral, Florida.
Gasoline prices are posted at a Mobil station in Candia, New Hampshire on April 30. Rising stockpiles and lowered demand are contributing to the low prices.
Christopher Ikemire prepares to test a customer at the Eastern Star Church on April 30 in Indianapolis, Indiana.
A pedestrian waits for a Chicago Transit Authority bus as several COVID-19 public service messages are projected on screens at the bus stop on April 30 in Chicago, Illinois.
President Donald Trump meets with New Jersey Governor Phil Murphy, New Jersey Health Commissioner Judith Persichilli (L) and Response coordinator for White House Coronavirus Task Force Deborah Birx (R) in the White House in Washington, D.C on April 30.
Demonstrators take part in an "American Patriot Rally," organized on April 30 by Michigan United for Liberty on the steps of the Michigan State Capitol in Lansing, Michigan.
Animal rights activists with PETA rally in front of the White House to demand that meat slaughterhouses, where hundreds of workers have tested positive for coronavirus, remain closed on April 30 in Washington, D.C.
USNS Comfort, the hospital ship leaves from New York City on April 30.
The Empire State Building is illuminated in blue to honor first responders and essential workers as the outbreak of the coronavirus continues in the Manhattan borough of New York, on April 29.
Physician Lauren Bernese administers a test for COVID-19 to Rachael Benson, a case manager at Interbay Village, a village of tiny houses managed by the Low Income Housing Institute, in Seattle, Washington, on April 29.
A sign indicates that the beach is still closed on April 29, in Miami Beach, Florida. The city of Miami Beach partially reopened parks and facilities including golf courses, tennis courts and marinas as it begins easing restrictions made due to the COVID-19 pandemic.
A person wearing a mask out of concern for the coronavirus walks past a sign advertising masks, on April 29, in Boston.
An unemployed worker checks looks at the State of Michigan unemployment site, on April 29, in Detroit. As of mid-April, about 26 million Americans had filed unemployment claims in the first five weeks since governments began ordering people to stay home and some businesses to close as a precaution against spreading the coronavirus. It's already the worst stretch of job losses in the Unites States' history.
Volunteers ready to load food into recipients cars at a food distribution point for people economically impacted by the coronavirus pandemic, organized by New Orleans City Councilman Jay Banks, on April 29.
A woman walks on the sidewalk next to a mural during COVID-19 pandemic, in the Pilsen neighborhood of Chicago, on April 29.
Members of the New York City Fire Department join in a round of applause outside NYU Langone Health to show their gratitude to medical staff and essential workers working on the front lines of the coronavirus pandemic, on April 29.
New cars are seen lined up next to the dock as the global outbreak of the coronavirus continues, at the Port of Los Angeles, California, on April 29.
A now hiring sign is displayed in front of a grocery store, on April 29, in Des Moines, Iowa. As of mid-April, about 26 million Americans had filed unemployment claims in the first five weeks of lockdown. The new unemployment data to be released on April 30, is expected to push that total even higher.
David Lopez and his mother Lupe, seen on April 29, at their Eagle Rock home where they have been sheltering in place. David lost his grandmother and Lupe her mother last week to coronavirus. David made a film about his grandmother's death to proof that the pandemic is real and not a hoax he said.
Construction workers wearing face masks walk past a sign in front of The Anthem, a popular live music venue, that displays a message of support on their marquee amid the coronavirus pandemic on April 29 in Washington, D.C.
Dr. Anthony Fauci director of the National Institute of Allergy and Infectious Diseases speaks during a meeting with President Donald Trump and Louisiana Governor John Bel Edwards in the White House in Washington, D.C on April 29.
Amid concerns over the spread of the coronavirus, a Dallas Police officer hands a sticker to a boy in a parking lot of a shopping center in Dallas, Texas on April 29.
Police, fire and rescue agencies arrive to cheers from medical staff at the main entrance to Central Florida Regional Hospital, in Sanford, for a "Heroes Thanking Heroes" parade on April 29 in Sanford, Florida.
A letter bearing the signature of President Donald Trump was sent to people who received a coronavirus economic stimulus payment as part of the Cares Act in Washington, D.C on April 29.
Coronavirus In The US
House Speaker Nancy Pelosi adjusts her face mask to protect against the spread of the new coronavirus as she attends a news conference to announce members of the House Select Committee on the Coronavirus Crisis on Capitol Hill in Washington D.C on April 29.
Messages of Support Written On a Boarded Up store in New York City on April 28.
A customer makes a purchase at a cafe in Grand Central Terminal on April 29 in New York.
A pedestrian walks past a sign in a shop window reading "We Will Return Boston Strong" after Massachusetts Governor Charlie Baker extended his stay-at-home advisory and his order closing non-essential businesses until May 18 because of the coronavirus disease (COVID-19) outbreak in Boston, Massachusetts on April 28.
Democrat Kweisi Mfume removes a face mask before addressing reporters during an election night news conference after he won the 7th Congressional District special election on April 28 in Baltimore, Maryland. Mfume defeated Republican Kimberly Klacik to finish the term of the late Rep. Elijah Cummings, retaking a Maryland congressional seat Mfume held for five terms before leaving to lead the NAACP.
Medical personnel attend a nightly 7 pm applause in their honor on April 28, outside NYU Langone Medical Center in the Manhattan borough of New York.
Hundreds of people line up for food donations, given to those impacted by the COVID-19 virus outbreak in Chelsea, Mass. on April 28.
49/49 SLIDES
Slideshow by photo services
Remdesivir is approved only for severely ill patients and only temporarily; formal approval must come later. Still, some doctors laboring in intensive care units embraced the drug as an important new weapon against a virus that is killing patients worldwide.
“It’s a great first step,” said Dr. Robert Finberg, chairman of the department of medicine at the University of Massachusetts Medical School.
Little about the early history of remdesivir, manufactured by Gilead Sciences, suggested the hopes now placed upon it.
Coronaviruses hold much more RNA than scientists once theorized a virus could. Many viruses that cause epidemics rely on this type of genetic material, and almost all mutate constantly. That is why flu viruses change from year to year.
In 2007, Dr. Denison discovered that coronaviruses have a powerful “proofreading” system. If an error occurs in copying RNA as the coronavirus replicates, it corrects the error. In lab experiments, coronaviruses that mutated were weaker, outcompeted by those without mutations.
Dr. Denison and other experts wondered if it might be possible to trick the virus with a drug that dodged the proofreading system and blocked the virus’s growing RNA chain, making it prematurely terminate.
Talking about this problem with another scientist at a meeting, Dr. Denison learned that Gilead Sciences had dozens of drugs that might do the trick. “All of these compounds had been shelved for one reason or another,” Dr. Denison said.
Most worked in lab tests to shut down coronaviruses, he found — some better than others. One of the best was GS-5734, now known as remdesivir. “I like to call it the Terminator,” Dr. Denison said.
Dr. Denison discovered remdesivir was just what they were seeking: a drug that slipped past the viruses’s powerful system to protect RNA, their genetic material. Remdesivir made growing chains of the viral RNA terminate prematurely, killing the virus.
Remdesivir killed every known coronavirus in Dr. Denison’s tests. Then researchers at the University of North Carolina found that the drug also killed the viruses in infected animals.
That included not just coronaviruses that cause the common cold, but also SARS and MERS — even a coronavirus that infects only mice.
But the drug failed a number of real-life tests — not just against hepatitis but also against Ebola in Africa. The drug languished, unapproved for any use — until a new coronavirus emerged.
As SARS-CoV-2, the virus that causes Covid-19, began to grow into a pandemic, many scientists realized that remdesivir might be the best solution at hand. It had already undergone animal testing and safety testing in humans.
So doctors began giving it to patients in studies without controls and even outside of studies altogether. Anecdotes fueled demand. Gilead sponsored some of these studies and gave the drug to doctors who treated hundreds of patients under compassionate use, a legal exemption permitting use of an unapproved drug to treat patients.
But none of this could demonstrate that a drug was helpful to patients. It took the federal trial, in which many patients were given a placebo, to show that remdesivir seems to have a modest effect.
Even a modest effect from the drug in hospitalized patients was a surprise, said Dr. Arnold Monto, an epidemiologist at the University of Michigan. He had expected that patients like those in the federal trial would not respond.
They were severely ill, and such patients often suffer not from their viral infections but from overreactions of the immune system. (That is why Tamiflu does not work well in severely ill flu patients, he added.)
“Thank God, we have something that works,” Dr. Monto said.
Not everyone is convinced that remdesivir will live up to its promise. A study in China, published this week in Lancet, found the drug offered no benefit to severely ill patients. And many experts want to see the data from the National Institute of Allergy and Infectious Diseases trial; so far, there have been only announcements about the results from administration officials.
Despite these questions, Gilead has been ramping up production and currently has 1.5 million vials on hand, enough for about 150,000 patients. Those will be provided to patients at no cost, said Daniel O’Day, the company’s chief executive.
He would not discuss what Gilead might charge in the long run, following a formal approval, but remdesivir is unlikely to be cheap, despite its origins in federally funded research.
“Gilead discovered this medicine and developed this medicine,” Mr. O’Day said. “We have been involved all the way.”
Some experts fear that taxpayers won’t get their due.
“Their pricing should reflect that the government not only invested substantial funds, but at risky stages,” said Dr. Aaron Kesselheim, a professor of medicine at Harvard University who studies drug pricing.
If Gilead reaps all the rewards, he added, “that doesn’t seem fair.”
No comments:
Post a Comment